Intervention: Pycnogenol

PYCNOVID

Switzerland
|
2023-2024
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Outpatient clinic
  • SARS-CoV-2
  • Post COVID-19 condition
  • Pharmacological intervention
  • Pycnogenol